Which statement about ACE inhibitors or ARBs in diabetic nephropathy is false?

Prepare for the Urinary System Pathologies Test with comprehensive quizzes. Master key concepts through flashcards and multiple-choice questions. Boost your confidence and be exam-ready!

Multiple Choice

Which statement about ACE inhibitors or ARBs in diabetic nephropathy is false?

Explanation:
The key idea is that blocking the RAAS with ACE inhibitors or ARBs protects the kidney by lowering pressure inside the glomeruli, which reduces protein leakage and slows the march of diabetic nephropathy. Angiotensin II tends to constrict the efferent arteriole, raising intraglomerular pressure; by inhibiting this effect, these medications lower the pressure, lessen albuminuria, and slow progression toward kidney failure. However, they do not reverse established structural damage or cure the disease—the nephropathy can still progress despite treatment. So the statement that they cure diabetic nephropathy is false, while their ability to reduce proteinuria, lower intraglomerular pressure, and slow progression is true.

The key idea is that blocking the RAAS with ACE inhibitors or ARBs protects the kidney by lowering pressure inside the glomeruli, which reduces protein leakage and slows the march of diabetic nephropathy. Angiotensin II tends to constrict the efferent arteriole, raising intraglomerular pressure; by inhibiting this effect, these medications lower the pressure, lessen albuminuria, and slow progression toward kidney failure. However, they do not reverse established structural damage or cure the disease—the nephropathy can still progress despite treatment. So the statement that they cure diabetic nephropathy is false, while their ability to reduce proteinuria, lower intraglomerular pressure, and slow progression is true.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy